Patent classifications
A61B5/029
ASSESSING HEMODYNAMICS USING ELECTRICAL IMPEDANCE MEASUREMENTS
Disclosed herein are systems, non-transitory computer readable media, and methods to employ electrical impedance-based devices in clinical setting to perform hemodynamic assessments. A system may include a plurality of electrodes; and a controller coupled to the plurality of electrodes. The controller may receive a sequence of impedance datasets. The controller may generate a corresponding impedance image. The controller may determine a pre-maneuver hemodynamic measurement from a first region of interest (ROI) from at least one impedance image prior to a maneuver. The controller may determine a post-maneuver hemodynamic measurement from the first ROI from at least one impedance image following the maneuver. The controller may receive at least one parameter associated with the maneuver. The controller may determine a hemodynamic figure of merit based at least on the pre-maneuver hemodynamic measurement, the post-maneuver hemodynamic measurement, and the at least one parameter associated with the maneuver.
SYSTEMS AND METHOD FOR IDENTIFYING THE NEED FOR MEASUREMENT OF CARDIAC OUTPUT
The present invention relates to a decision support system (DSS), a medical monitoring system (100), and a corresponding method for identifying the need for measurement of cardiac output (CO) based on one or more comparisons (COMP1, COMP2) in a physiological model. More specifically, for identifying when an approximated value of CO cannot be correct due to circulatory compromise and as such that another estimated or measured value of CO is required.
SYSTEMS AND METHOD FOR IDENTIFYING THE NEED FOR MEASUREMENT OF CARDIAC OUTPUT
The present invention relates to a decision support system (DSS), a medical monitoring system (100), and a corresponding method for identifying the need for measurement of cardiac output (CO) based on one or more comparisons (COMP1, COMP2) in a physiological model. More specifically, for identifying when an approximated value of CO cannot be correct due to circulatory compromise and as such that another estimated or measured value of CO is required.
NONINVASIVE METHOD AND SYSTEM FOR ESTIMATING MAMMALIAN CARDIAC CHAMBER SIZE AND MECHANICAL FUNCTION
The present disclosure generally relates to systems and methods and systems of a noninvasive technique for characterizing cardiac chamber size and cardiac mechanical function. A mathematical analysis of three-dimensional (3D) high resolution data may be used to estimate chamber size and cardiac mechanical function. For example, high-resolution mammalian signals are analyzed across multiple leads, as 3D orthogonal (X,Y,Z), or 10-channel data, for 30 to 800 seconds, to derive estimates of cardiac chamber size and cardiac mechanical function. Multiple mathematical approaches may be used to analyze the dynamical and geometrical properties of the data.
SYSTEMS AND METHODS FOR DETERMINING CARDIAC OUTPUT
The systems and methods described herein determine metrics of cardiac or vascular performance, such as cardiac output, and can use the metrics to determine appropriate levels of mechanical circulatory support to be provided to the patient. The systems and methods described determine cardiac performance by determining aortic pressure measurements (or other physiologic measurements) within a single heartbeat or across multiple heartbeats and using such measurements in conjunction with flow estimations or flow measurements made during the single heartbeat or multiple heartbeats to determine the cardiac performance, including determining the cardiac output. By utilizing a mechanical circulatory support system placed within the vasculature, the need to place a separate measurement device within a patient is reduced or eliminated. The system and methods described herein may characterize cardiac performance without altering the operation of the heart pump (e.g., without increasing or decreasing pump speed).
ESTIMATING A VALUE ASSOCIATED WITH HEART WALL TENSION
A method of estimating a value associated with heart wall tension. The method comprises: using motion data recorded with a sensor in communication with the heart to identify motion in the heart; and estimating a value associated with heart wall tension based on the identified motion in the heart. The motion in the heart that forms the basis of the estimation may be a vibration in the heart wall. A heat monitoring system for carrying out the method of estimating a value associated with heart wall tension comprises a sensor configured to be placed in communication with the heart in order to identify motion in the heart; and a data processing device arranged to receive motion data from the sensor and to then carry out the steps of the method.
ESTIMATING A VALUE ASSOCIATED WITH HEART WALL TENSION
A method of estimating a value associated with heart wall tension. The method comprises: using motion data recorded with a sensor in communication with the heart to identify motion in the heart; and estimating a value associated with heart wall tension based on the identified motion in the heart. The motion in the heart that forms the basis of the estimation may be a vibration in the heart wall. A heat monitoring system for carrying out the method of estimating a value associated with heart wall tension comprises a sensor configured to be placed in communication with the heart in order to identify motion in the heart; and a data processing device arranged to receive motion data from the sensor and to then carry out the steps of the method.
Method to Quantify the Hemodynamic and Vascular Properties in Vivo Arterial Waveform Measurements
Disclosed herein are in vivo non-invasive methods and devices for the measurement of the hemodynamic parameters, such as blood pressure, cardiac output, stroke volume and vascular tone, of a subject, and the mechanical anelastic in vivo properties of the subject's arterial blood vessels. An exemplary method requires obtaining the peripheral pulse volume waveform (PVW), the peripheral pulse pressure waveform (PPW), and the peripheral pulse velocity waveform (PUW) from the same artery; calculating the time phase shift between the PPW and PVW, and the plot of pulse pressure versus pulse volume; and determining the blood pressures and power law components of the anelastic model from the waveforms PPW and PVW, the cardiac output from the waveforms PPW and PUW, and the quality factor of the artery based upon the calculations. The disclosed methods and devices can be used to diagnose and treat cardiovascular disease in a subject in need thereof.
System and method for closed-loop patient-adaptive hemodynamic management
A system and method for patient-adaptive hemodynamic management is described. One embodiment includes a system for hemodynamic management including transfusion, volume resuscitation with intravenous fluids, and medications, utilizing monitored hemodynamic parameters including the described dynamic predictors of fluid responsiveness, and including an intelligent algorithm capable of adaptation of the function of the device to specific patients.
System and method for closed-loop patient-adaptive hemodynamic management
A system and method for patient-adaptive hemodynamic management is described. One embodiment includes a system for hemodynamic management including transfusion, volume resuscitation with intravenous fluids, and medications, utilizing monitored hemodynamic parameters including the described dynamic predictors of fluid responsiveness, and including an intelligent algorithm capable of adaptation of the function of the device to specific patients.